The rational use of qinghaosu and its derivatives: what is the future of new compounds?
In Thailand, artesunate and artemether are the mainly used antimalarials for treatment of severe or multidrug resistant falciparum malaria. However, their availability (supply) and the registration requirements are the major limitations for their large-scale use. At Bangkok Hospital for Tropical Diseases, Thailand, we have studied the new artemisinin derivatives, dihydroartemisinin and arteether, and artesunate suppositories. We found that the three preparations are well tolerated, safe, and efficacious.
Looareesuwan
S
S
Hospital for Tropical Disease, Faculty of Tropical Medicine/Mahidol University, Bangkok, Thailand. tmslr@mahidol.ac.th
Wilairatana
P
P
D000284:Administration, Oral; D000285:Administration, Rectal; D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000737:chemistry* / Q000600:supply & distribution / Q000627:therapeutic use*; D037621:Artemisinins; D000077332:Artesunate; D004351:Drug Resistance; D004335:Drug and Narcotic Control / Q000458:organization & administration; D005260:Female; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D008297:Male; D008875:Middle Aged; D012042:Registries; D012717:Sesquiterpenes / Q000737:chemistry* / Q000600:supply & distribution / Q000627:therapeutic use*; D013488:Suppositories; D013785:Thailand
D000962:Antimalarials; D037621:Artemisinins; D012717:Sesquiterpenes; D013488:Suppositories; D000077332:Artesunate; C039060:artenimol; C031327:artemisinin; C055141:artemotil